NPTN · Neophotonics Corp - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Annual Quarterly

Income Statement

Line item	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Revenue	$290.29M	$371.16M	$356.80M	$411.42M	-	-
Cost of Revenue	$222.70M	$268.08M	$267.99M	$294.29M	-	-
Gross Profit	$67.59M	$103.08M	$88.81M	$66.17M	$61.48M	$117.13M
R&D	$56.49M	$56.10M	$57.63M	$53.82M	$58.29M	$57.38M
SG&A	$30.46M	$30.57M	$29.76M	$30.40M	$34.45M	$34.41M
Total Operating Expenses	$105.42M	$99.52M	$103.36M	$107.83M	$112.84M	$114.11M
D&A	$30.65M	$30.65M	$30.79M	$31.11M	$28.35M	$22.40M
Operating Income	($37.83M)	$3.57M	($14.54M)	($41.66M)	($51.36M)	$3.02M
Interest Expense	$969.0K	$1.18M	$1.92M	$2.49M	$1.36M	$402.0K
Income Tax	$1.71M	$1.20M	$1.63M	$1.33M	$909.0K	$3.60M
Net Income	($40.72M)	($4.37M)	($17.08M)	($43.64M)	($53.33M)	($205.0K)
EPS - Basic	($0.78)	($0.09)	($0.36)	($0.97)	($1.23)	$0.00
EPS - Diluted	($0.78)	($0.09)	($0.36)	($0.97)	($1.23)	$0.00

Balance Sheet

Line item	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Cash & Equivalents	$77.83M	$95.12M	$70.47M	$58.19M	$78.91M	$82.50M
Accounts Receivable	$55.32M	$45.23M	$68.89M	$74.75M	$67.23M	$80.61M
Inventory	$52.90M	$46.90M	$46.93M	$52.16M	$67.30M	$48.24M
Accounts Payable	$58.13M	$43.54M	$58.55M	$58.40M	$69.02M	$84.77M
Current Assets	$230.06M	$235.58M	$230.75M	$233.21M	$264.64M	$270.80M
Total Assets	$305.57M	$323.66M	$334.68M	$340.58M	$402.95M	$390.89M
Current Liabilities	$105.97M	$88.82M	$109.08M	$116.38M	$153.87M	$146.33M
Long-term Debt	-	$30.33M	$39.24M	$50.45M	$40.56M	$10.21M
Total Liabilities	$152.61M	$143.26M	$174.47M	$180.34M	$208.50M	$165.48M
Stockholders' Equity	$152.96M	$180.41M	$160.21M	$160.24M	$194.45M	$225.41M
Retained Earnings	($459.63M)	($418.91M)	($414.55M)	($397.47M)	($352.01M)	($298.68M)

Cash Flow

Line item	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Operating Cash Flow	($20.59M)	$54.93M	$34.69M	$19.59M	$53.84M	$53.84M
Investing Cash Flow	($10.06M)	($33.37M)	($7.45M)	($11.78M)	($49.47M)	($49.47M)
Financing Cash Flow	$12.80M	($8.54M)	($14.88M)	($19.46M)	$3.52M	$3.52M
CapEx	$11.50M	$13.87M	$9.53M	$14.87M	$47.41M	$51.69M
Free Cash Flow	($32.09M)	$41.06M	$25.16M	$4.73M	$6.43M	$2.14M

Ratios

Metric	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Profitability
Gross margin	23.3%	27.8%	24.9%	16.1%	-	-
Operating margin	-13.0%	1.0%	-4.1%	-10.1%	-	-
EBITDA margin	-2.5%	9.2%	4.6%	-2.6%	-	-
Net margin	-14.0%	-1.2%	-4.8%	-10.6%	-	-
Free cash flow margin	-11.1%	11.1%	7.1%	1.1%	-	-
FCF / Net income	0.79	-9.40	-1.47	-0.11	-0.12	-10.45
R&D / Revenue	19.5%	15.1%	16.2%	13.1%	-	-
SG&A / Revenue	10.5%	8.2%	8.3%	7.4%	-	-
Effective tax rate	-	-	-	-	-	106.0%
Return on assets	-13.3%	-1.3%	-5.1%	-12.8%	-13.2%	-0.1%
Return on equity	-26.6%	-2.4%	-10.7%	-27.2%	-27.4%	-0.1%
Return on invested capital	-	1.3%	-5.8%	-15.6%	-17.3%	0.6%
Liquidity
Current ratio	2.17	2.65	2.12	2.00	1.72	1.85
Quick ratio	1.67	2.12	1.69	1.56	1.28	1.52
Cash ratio	0.73	1.07	0.65	0.50	0.51	0.56
Leverage
Debt / Equity	-	0.17	0.24	0.31	0.21	0.05
Debt / Assets	-	0.09	0.12	0.15	0.10	0.03
Debt / EBITDA	-	0.89	2.42	-	-	0.40
Interest coverage	-39.0x	3.0x	-7.6x	-16.7x	-37.7x	7.5x
Equity multiplier	2.00	1.79	2.09	2.13	2.07	1.73
Liabilities / Assets	0.50	0.44	0.52	0.53	0.52	0.42
Efficiency
Asset turnover	0.95	1.15	1.07	1.21	-	-
Inventory turnover	4.21	5.72	5.71	5.64	-	-
Days sales outstanding	70d	44d	70d	66d	-	-
Days inventory outstanding	87d	64d	64d	65d	-	-
Days payable outstanding	95d	59d	80d	72d	-	-
Cash conversion cycle	61d	49d	55d	59d	-	-
Valuation
P / E	-	-	-	-	-	-
P / B	-	-	-	-	-	-
P / S	-	-	-	-	-	-
EV / EBITDA	-	-	-	-	-	-
Growth
Revenue growth (YoY)	-21.8%	4.0%	-13.3%	-	-	-
Revenue CAGR (3y)	-11.0%	-	-	-	-	-
Revenue CAGR (5y)	-	-	-	-	-	-
Gross profit growth (YoY)	-34.4%	16.1%	34.2%	7.6%	-47.5%	18.2%
Operating income growth (YoY)	-	-	65.1%	18.9%	-	-23.6%
Net income growth (YoY)	-832.6%	74.4%	60.9%	18.2%	-25916.1%	-
EPS growth (YoY)	-766.7%	75.0%	62.9%	21.1%	-	-
EPS CAGR (3y)	-	-	-	-	-	-
EPS CAGR (5y)	-	-	-	-	-	-
FCF growth (YoY)	-	63.2%	432.0%	-26.4%	199.9%	-77.0%
FCF CAGR (5y)	-	34.6%	-	-	-	-22.4%
Book value growth (YoY)	-15.2%	12.6%	-0.0%	-17.6%	-13.7%	6.5%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2021-12-31.

Product / service

$290.29M total

High Speed$271.31M · 93.5%

Network Productsand Solution$18.98M · 6.5%

Geographic

$290.29M total

TH$94.36M · 32.5%

CN$89.23M · 30.7%

Other$63.53M · 21.9%

MY$27.00M · 9.3%

MX$16.17M · 5.6%

Stability scores

Altman Z′

FY 2021 · bankruptcy risk

0.00

Distress

Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.

Piotroski F-score

FY 2021 · 9-point quality

1/9

Weak

✗Net income positive
✗Operating cash flow positive
✗ROA improved YoY
✓Cash flow > net income
-Long-term debt decreased
✗Current ratio improved
✗No share dilution
✗Gross margin improved
✗Asset turnover improved

Peer comparison

Same SIC group: Semiconductors & Related Devices

Company	Revenue (last FY)	Net margin	ROE
AMKR	$6.71B	5.6%	8.4%
LSCC	$523.26M	0.6%	0.4%
CRDO	-	-	-
FSLR	$5.22B	29.3%	16.0%
NVDA	$215.94B	55.6%	76.3%

Comparing NEOPHOTONICS CORP against the 5 most active filers in the same SIC group.